C. Piazza

C. Piazza

Directeur Général chez
IGL Pharma, Inc.
79 ans
Health Technology
Consumer Services
Commercial Services

Profil

C.
Richard Piazza
was the founder of QSAM Biosciences, Inc. (founded in 2004) where he served as the Executive Chairman from 2020 to 2024.
He is currently the President & Chief Executive Officer of IGL Pharma, Inc. (since 2017) and the Chairman of NovaScan, Inc. (since 2018).
In the past, he held positions as the President & Chief Executive Officer of Maxia Pharmaceuticals, Inc. (2001-2002), VitaGen, Inc. (2002-2003), and TheraFuse, Inc. (2003-2004).
He also served as the Chief Executive Officer of SynVivo, Inc. (2014-2016) and as the Managing Director of Healthios Capital Markets LLC (2004-2007) and the Managing Partner of La Jolla Capital Partners, Inc. (2004-2007).
Additionally, he has held the title of Chairman at Chemokine Therapeutics Corp.
Dr. Piazza obtained a doctorate degree from the University of Leeds, a graduate degree from the State University of New York at Buffalo, and an undergraduate degree from The State University of New York.

Postes actifs de C. Piazza

SociétésPosteDébut
Directeur Général 01/01/2017
Président 01/11/2018

Anciens postes connus de C. Piazza

SociétésPosteFin
Fondateur 02/05/2024
Directeur Général 01/01/2016
La Jolla Capital Partners, Inc.
Corporate Officer/Principal 01/01/2007
Corporate Officer/Principal 01/01/2007
President 01/09/2004
Voir l'expérience en détail de C. Piazza

Formation de C. Piazza

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

25

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Finance

La Jolla Capital Partners, Inc.

Health Technology

Process Industries

Health Services

Health Technology

Technology Services